1. Home
  2. NTRA vs ZBRA Comparison

NTRA vs ZBRA Comparison

Compare NTRA & ZBRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • ZBRA
  • Stock Information
  • Founded
  • NTRA 2003
  • ZBRA 1969
  • Country
  • NTRA United States
  • ZBRA United States
  • Employees
  • NTRA N/A
  • ZBRA N/A
  • Industry
  • NTRA Medical Specialities
  • ZBRA Industrial Machinery/Components
  • Sector
  • NTRA Health Care
  • ZBRA Industrials
  • Exchange
  • NTRA Nasdaq
  • ZBRA Nasdaq
  • Market Cap
  • NTRA 22.1B
  • ZBRA 21.3B
  • IPO Year
  • NTRA 2015
  • ZBRA 1991
  • Fundamental
  • Price
  • NTRA $162.31
  • ZBRA $311.05
  • Analyst Decision
  • NTRA Strong Buy
  • ZBRA Buy
  • Analyst Count
  • NTRA 17
  • ZBRA 11
  • Target Price
  • NTRA $165.88
  • ZBRA $382.00
  • AVG Volume (30 Days)
  • NTRA 1.3M
  • ZBRA 719.8K
  • Earning Date
  • NTRA 02-27-2025
  • ZBRA 02-13-2025
  • Dividend Yield
  • NTRA N/A
  • ZBRA N/A
  • EPS Growth
  • NTRA N/A
  • ZBRA 77.97
  • EPS
  • NTRA N/A
  • ZBRA 10.18
  • Revenue
  • NTRA $1,531,955,000.00
  • ZBRA $4,981,000,000.00
  • Revenue This Year
  • NTRA $56.11
  • ZBRA $9.96
  • Revenue Next Year
  • NTRA $9.76
  • ZBRA $6.17
  • P/E Ratio
  • NTRA N/A
  • ZBRA $30.56
  • Revenue Growth
  • NTRA 54.94
  • ZBRA 8.66
  • 52 Week Low
  • NTRA $69.91
  • ZBRA $266.75
  • 52 Week High
  • NTRA $183.00
  • ZBRA $427.76
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 40.88
  • ZBRA 23.39
  • Support Level
  • NTRA $168.15
  • ZBRA $312.37
  • Resistance Level
  • NTRA $180.41
  • ZBRA $331.24
  • Average True Range (ATR)
  • NTRA 7.08
  • ZBRA 11.90
  • MACD
  • NTRA -1.24
  • ZBRA -5.93
  • Stochastic Oscillator
  • NTRA 14.58
  • ZBRA 3.62

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About ZBRA Zebra Technologies Corporation

Zebra Technologies is a leading provider of automatic identification and data capture technology to enterprises. Its solutions include barcode printers and scanners, mobile computers, and workflow optimization software. The firm primarily serves the retail, transportation logistics, manufacturing, and healthcare markets, designing custom solutions to improve efficiency at its customers.

Share on Social Networks: